Explainer: How worried should we be about reports of blood clots and AstraZeneca's vaccine?


  • World
  • Thursday, 18 Mar 2021

Vials labelled "AstraZeneca COVID-19 Coronavirus Vaccine" and a broken syringe are seen in front of a displayed AstraZeneca logo in this illustration taken March 15, 2021. REUTERS/Dado Ruvic/Illustration

FRANKFURT/PARIS (Reuters) - Europe's drug watchdog is reviewing a small number of reports of bleeding, blood clots and low platelet counts in people who have received AstraZeneca's coronavirus vaccine. The European Medicines Agency (EMA) has said it has so far found no causal link between the vaccine and the incidents. The World Health Organization has also said there was no proven link and people should not panic. At least 13 EU member states including Germany, France, Italy have suspended use of the shot pending the outcome of EMA's probe.

Here's what we know so far:

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

This AI-focused chip is powered by light
Study warns users about health information on TikTok
Canada's British Columbia calls off drug decriminalization pilot project
3 killed after building collapses in north Nigeria
Aerosmith frontman Steven Tyler wins dismissal for good of sexual assault lawsuit
Chinese company to build photovoltaic factory in Saudi port
Nearly 23 pct of Canadian population reported food insecurity in 2022
Canada announces investment to grow semiconductor supply chain
U.S. stocks close higher
Feature: Chinese firms eager to showcase new products at Spain seafood fair

Others Also Read